Does PERTUZUMAB Cause Hepatic function abnormal? 185 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 185 reports of Hepatic function abnormal have been filed in association with PERTUZUMAB (PERJETA). This represents 0.8% of all adverse event reports for PERTUZUMAB.
185
Reports of Hepatic function abnormal with PERTUZUMAB
0.8%
of all PERTUZUMAB reports
8
Deaths
83
Hospitalizations
How Dangerous Is Hepatic function abnormal From PERTUZUMAB?
Of the 185 reports, 8 (4.3%) resulted in death, 83 (44.9%) required hospitalization, and 5 (2.7%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PERTUZUMAB. However, 185 reports have been filed with the FAERS database.
What Other Side Effects Does PERTUZUMAB Cause?
Diarrhoea (3,343)
Off label use (1,886)
Fatigue (1,672)
Nausea (1,669)
Myelosuppression (1,311)
Disease progression (1,142)
Vomiting (1,096)
Dyspnoea (987)
Neuropathy peripheral (983)
Pyrexia (926)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which PERTUZUMAB Alternatives Have Lower Hepatic function abnormal Risk?
PERTUZUMAB vs PERTUZUMAB\TRASTUZUMAB
PERTUZUMAB vs PETROLATUM
PERTUZUMAB vs PEVONEDISTAT
PERTUZUMAB vs PEXIDARTINIB
PERTUZUMAB vs PHENACETIN